High risk prostate carcinoma
Clinical trials for High risk prostate carcinoma explained in plain language.
Never miss a new study
Get alerted when new High risk prostate carcinoma trials appear
Sign up with your email to follow new studies for High risk prostate carcinoma, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Prostate cancer combo trial pulled before it began
Disease control CancelledThis study was designed to test whether adding the immunotherapy drug pembrolizumab (Keytruda) to standard hormone therapy and radiation could improve outcomes for men with high-risk localized prostate cancer. The trial was withdrawn before enrolling any participants, so no resul…
Matched conditions: HIGH RISK PROSTATE CARCINOMA
Phase 2 • Sponsor: OHSU Knight Cancer Institute • Aim: Disease control
Last updated Jun 27, 2026 07:51 UTC
-
New MRI could reveal prostate cancer treatment success in weeks
Knowledge-focused OngoingThis study is testing whether a special type of MRI scan can show early signs that high-risk prostate cancer is responding to treatment. About 32 men will get the scan before and during therapy, and results will be compared to standard tissue exams after surgery. The goal is to f…
Matched conditions: HIGH RISK PROSTATE CARCINOMA
Phase 2 • Sponsor: Ivan de Kouchkovsky, MD • Aim: Knowledge-focused
Last updated Sep 06, 2026 00:00 UTC